Wellness: It's all in your head, literally

Today’s market patterns show consumer and scientific interest converging on the nervous system, from its dysregulation to its protection, and how it impacts everything from gut health to policy.

In today's read: 1. Nervous System as the New Center of Wellness · 2. Sleep Irregularity is the Silent Killer · 3. Big Biotech Targets Neurodegeneration · 4. Food Systems Undermine Gut-Immune Health

1. Nervous System as the New Center of Wellness

The market's finally catching on: emotional 'too muchness' and even physical symptoms are often expressions of a dysregulated nervous system. New products and practices are emerging to address this core regulatory system, moving beyond mere symptom management.

Watch for more 'somatics'-branded offerings and apps that promise to track or 'regulate' your internal state. Investors will chase anything with a 'nervous system' tag, true or not. This re-centering of the nervous system as the control panel changes how we approach health.

Evidence from today:

• Wellness industry rediscovers 'Somatics' to regulate the body — The Atlantic - Health — The Atlantic reports on the surging interest in "somatics" within wellness circles, repackaging decades-old practices for modern life. This trend highlights how the industry is trying to address nervous system dysregulation through movement and interoception, often with new branding.
• Neuroqueering suggests 'too muchness' is a nervous system thing, not a flaw — Aeon — A new Aeon essay explores 'neuroqueering,' proposing that intense emotional expressions or 'too muchness' aren't personal failings but rather expressions of diverse nervous system states. It reframes classic historical anecdotes, like Hans Christian Andersen's garden tantrum, through this lens. The idea is to shift perspective from social deviance to neurodivergence, offering a less pathologizing way to understand emotional intensity.
• Creatine is a top brain health supplement for Mindbodygreen writer — Mindbodygreen — Mindbodygreen's Molly Knudsen reviewed creatine for brain health, noting improved energy and focus in a week. She took 5g of creatine daily, reporting noticeable changes in mental clarity. This signals a growing consumer interest in accessible, science-backed nootropics.

2. Sleep Irregularity is the Silent Killer

It's not just how much you sleep, but when. Inconsistent sleep-wake times throw off your body's circadian rhythm, which in turn messes with blood pressure regulation and brain recovery. This adds another layer to sleep's impact on longevity.

Expect more wearables and apps to focus on 'sleep regularity' scores, not just total hours. The market will soon demand solutions for night owls who can't switch off, and employers might start paying attention to 'chronotype optimization' for recovery and productivity.

Evidence from today:

• Irregular Sleep Raises Blood Pressure Risk by 46% — Mindbodygreen — New research from Vanderbilt University linked irregular sleep schedules to a 46% higher risk of hypertension, showing that even good sleep quantity can't offset inconsistent timing. The study, published in Hypertension, tracked over 500 participants for six years, finding that big swings in sleep and wake times mess with your body's pressure regulation.
• Night Owls' Brains Stay Busy, Delaying Recovery — Mindbodygreen — New research suggests evening chronotypes struggle to switch off work thoughts, even hours after their shift. This delayed mental recovery can impact brain function and lead to burnout. The finding comes from a study by researchers at the University of Fribourg, Switzerland, using cognitive tasks and EEG monitoring.

3. Big Biotech Targets Neurodegeneration

New gene therapies and AI-driven drug discovery are moving into clinical trials for Alzheimer's. The focus is on early prediction and targeted interventions that can actually alter the disease progression, rather than just managing symptoms.

This signals a shift from broad-stroke pharma to precision biotech for complex neurological diseases. Expect big funding rounds for companies like Tetraneuron and more AI partnerships like NorthStrive/Yuva. The race for early diagnostics and preventative therapies for cognitive decline is heating up, with real science finally showing up.

Evidence from today:

• Spanish Gene Therapy for Alzheimer's Enters Human Trials in Australia — El Médico Interactivo — Tetraneuron, a Spanish biotech, received approval to start human trials in Australia for TET-101, a gene therapy targeting moderate Alzheimer's. The company also secured over €4.3 million in public funding. This moves a new mechanism against neurodegeneration closer to patients.
• Brain MRI predicts early dementia progression — Healio - Psychiatry & Mental Health — New research in Neurology suggests that specific brain atrophy patterns seen on MRI scans can predict how fast early-onset dementia progresses. Researchers, led by Alexandra Touroutoglou from Harvard Medical School, found that atrophy in key areas associated with early Alzheimer's helps forecast the timeline of cognitive decline. This could mean earlier, more precise insights into how someone's brain health will change.
• Oligomerix names new interim CEO to push Alzheimer's drug — Longevity Technology — Oligomerix just appointed Dr. Cara Cassino as interim CEO, tapping her 25 years of drug development experience to advance its Alzheimer's pipeline. Cassino has over 25 FDA and EMA drug approvals under her belt from previous roles at major pharma companies like Boehringer Ingelheim, signaling a push for speed to market in the neurodegenerative space.

4. Food Systems Undermine Gut-Immune Health

From antibiotic-laden meat to policies that ignore soil diversity, global food systems are actively working against our gut and immune health. This creates silent inflammations and increases disease vulnerability, impacting everything from allergies to chronic conditions.

This is a quiet but persistent threat to public health. Watch for increasing consumer demand for locally sourced, 'clean' foods and a surge in novel allergy treatments focused on the gut. Policy makers will eventually have to reconcile efficiency with actual population health outcomes, or we'll all pay the price.

Evidence from today:

• Wizard Wellness launches microbiome-focused allergy care, expands to major retailers — Glossy — Former beauty executive Lorne Lucree launched Wizard Wellness, a drug-free, microbiome-focused allergy product line, in January. Nine months later, the brand is in Walmart, CVS, and Target. It's an interesting play leveraging beauty's rapid retail expansion tactics for health products.
• Brazilian meat linked to antibiotic-resistant superbugs — The Conversation - Health & Medicine — Brazilian meat imports contribute to antibiotic resistance, with high rates of multi-drug resistant E. coli found in imported products. This issue is not just a hospital problem but extends to global food production, raising concerns about superbugs entering consumer supply chains.
• Alpha-Gal Syndrome Antibodies Found in 1-in-4 in US Hotspots — Deutsches Ärzteblatt — New research in Morbidity and Mortality Weekly Report found that nearly one in four people (25%) in US Alpha-gal syndrome (AGS) high-risk areas have antibodies for the tick-borne allergy. The study, led by Dr. Melanie Firestone, suggests a significant portion of the population might be silently sensitized to red meat from a single tick bite. It's a wake-up call for how a tiny insect can rewire a nervous system's response to food.
• Singapore's food security plan bets against gut and soil health — Aeon — Singapore is securing its water supply but struggling with food, prioritizing efficiency over self-sufficiency in its food strategy. This approach focuses on importing most food and growing specialty items indoors, but it overlooks the gut microbiome's connection to diverse, locally grown produce. The essay draws lessons for national policy on feeding its population.

Also moved today

• Lifelong app tracks family health data, centralizes medical records — Product Hunt — Health & Fitness — Lifelong app launches to centralize family health data, aiming to reduce caregiver burden but also raising questions about data privacy and aggregation.
• Daily 30-Minute Walk Offers Brain Boost, Mood Lift — Mindbodygreen — Daily 30-minute walks boost brain function and mood, showing simple movement still packs a punch for cognitive health.
• One in four deceased NFL players had CTE, new study finds — Healio - Psychiatry & Mental Health — Nearly a quarter of deceased NFL players had CTE, a stark reminder of long-term nervous system damage from repetitive head trauma in sports.
• OpenEvidence releases new AI models for clinical use — STAT Health Tech — OpenEvidence released new AI models to help clinicians process medical research faster, streamlining diagnostics and treatment pathways.
• Danes eat world's most sugar, stay lean: new study — Videnskab.dk (Health) — Danes eat the most sugar but stay lean due to high physical activity, challenging one-size-fits-all dietary advice.
• Smart Toilets Use AI to Scan Your Poop for Health Data — Wired Science — Smart toilets are hitting the market to analyze stool for gut health, but experts say they're more for data collection than actual diagnostic use right now.
• Study finds short workout, caffeine can blunt sleep deprivation's cognitive hit — Mindbodygreen — A short workout or caffeine can blunt the cognitive hit from sleep deprivation, offering a buffer, not a fix, for occasional bad sleep.
• FDA's TEMPO pilot lets AI medical devices launch pre-authorization — STAT Health Tech — The FDA's TEMPO pilot allows AI medical devices to launch pre-authorization, speeding up market access for digital mental health tools.
• Vitamin D might rebalance gut lining in IBD patients, study shows — Mindbodygreen — Vitamin D might rebalance the gut lining in IBD patients, suggesting a low-cost intervention for a chronic inflammatory condition.
• Working sick from home extends recovery, blurs rest-work lines — Videnskab.dk (Health) — Working sick from home extends recovery and blurs the lines between work and rest, affecting your body's ability to heal fully.

New this week in wellness goods

• Lifelong app tracks family health data, centralizes medical records — global — Lifelong, a new app from The Family Health Company, launched to centralize health data for an entire family. It pulls records into one place, aiming to reduce caregiver burden and offer a clearer picture of collective health. Think shared medical history, but with a privacy layer.
• Wizard Wellness launches microbiome-focused allergy care, expands to major retailers — US — Former beauty executive Lorne Lucree launched Wizard Wellness, a drug-free, microbiome-focused allergy product line, in January. Nine months later, the brand is in Walmart, CVS, and Target. It's an interesting play leveraging beauty's rapid retail expansion tactics for health products.

Signal map

North America: 17 · Europe: 12 · Global: 11 · Oceania: 2 · Nordics: 2

What I'd watch next

Keep an eye on how the FDA's TEMPO pilot impacts AI device market saturation. Also, any further policy shifts on public health funding in Europe will signal where innovation in care is truly prioritized.

Where this fits at Kokorology

Understanding these body-market intersections is key to building durable solutions. I find that applying these insights to my own baseline helps me spot patterns faster—that's why I created The Nervous System Journal, a tool for daily self-monitoring that brings this kind of insight to your everyday.